Lung AI vs LINQ II Insertable Cardiac Monitor
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Multiple (e.g., RevealDx, Optellum, LungLife AI, Qure.ai, Arterys, DeepHealth, HeartLung.AI)
VS
AI Verdict
Tool A, Exo's Lung AI, is a handheld ultrasound platform that uses AI for real-time imaging and diagnostic support for cardiac and lung conditions. In contrast, Tool B, Medtronic's LINQ II, is an insertable cardiac monitor leveraging AI for long-term, continuous heart rhythm monitoring and arrhythmia detection. While both are AI-powered cardiology tools, they address different diagnostic phases and employ distinct technological approaches.
Choose Lung AI if…
Choose Lung AI if you require immediate, real-time diagnostic imaging at the point of care for conditions affecting the lungs or heart. This handheld, AI-powered ultrasound is ideal for emergency medicine, critical care, or situations demanding rapid assessment and on-device processing without internet connectivity, enabling quick decisions regarding pleural effusion, consolidation, or cardiac indicators.
View Lung AI →Choose LINQ II Insertable Cardiac Monitor if…
Choose the LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous, and discreet monitoring of heart rhythms for the diagnosis of infrequent or asymptomatic arrhythmias. This AI-powered insertable device provides up to 4.5 years of monitoring with remote management capabilities, making it suitable for patients needing extended observation for conditions like unexplained syncope or cryptogenic stroke.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Lung AI | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Unknown | Enterprise |
| Deployment | Cloud-based, integrated with existing platforms (e.g., RapidAI), and potentially on-premise. | Hybrid |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Lung AI | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Product Name | Lung AI | LINQ II Insertable Cardiac Monitor |
| Company | Exo | Medtronic |
| Tagline | Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning. | Advanced insertable cardiac monitoring with AI-powered accuracy and remote management. |
| Description Summary | A high-performance, handheld ultrasound platform that uses artificial intelligence for imaging and therapeutic applications, empowering healthcare professionals to make critical, real-time decisions. | An advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. |
| Primary AI Application | AI-powered detection of pleural effusion, consolidation/atelectasis, and automated AI-based indicators for cardiac conditions. | AccuRhythmu2122 AI algorithms for enhanced accuracy in diagnosing arrhythmias and innovative PVC detection algorithm. |
| Target Specialties | Cardiology, Emergency Medicine, Pulmonology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Lung AI and LINQ II Insertable Cardiac Monitor.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Lung AI, integrated with the Exo Iris handheld ultrasound, is designed for real-time, point-of-care diagnostic imaging, enabling immediate clinical decisions for cardiac and lung conditions at the bedside. LINQ II provides continuous, long-term heart rhythm monitoring for up to 4.5 years, integrating into a workflow focused on chronic arrhythmia detection and remote patient management through its mobile app and home communicator.
Lung AI uses AI for real-time detection of conditions like pleural effusion and consolidation/atelectasis, with guided image capture to optimize scan quality and improve diagnostic accuracy for clinicians of varying expertise. LINQ II features AccuRhythm AI algorithms that significantly reduce false alerts for atrial fibrillation and pause episodes, enhancing the accuracy of arrhythmia diagnosis and saving clinicians substantial review time.
Lung AI extends its utility to Emergency Medicine and Pulmonology, offering real-time diagnostic imaging for a broader range of acute and chronic lung conditions in addition to cardiac assessments. LINQ II is primarily focused on Cardiology, with a specific pediatric indication for arrhythmia monitoring in patients aged 2 and older.
Exo offers 'Exo U,' an AI-powered POCUS education and training platform, to facilitate rapid learning and proficiency with the Lung AI handheld ultrasound device, benefiting both novice and experienced users. Medtronic Academy provides learning plans, videos, and courses for LINQ II, covering insertion workflows and patient management on the CareLink Network, with options for continuing education credits.
Lung AI's on-device AI processing allows it to operate without internet, simplifying deployment in various clinical settings and eliminating lag for real-time diagnostics. LINQ II's remote programming and data transmission via the MyCareLink Heart app or home communicator are designed for efficient patient management and data flow, which can scale across multiple sites through the CareLink network.
Lung AI offers immediate time-to-value through real-time, point-of-care diagnostics, enabling rapid decision-making and potentially faster patient management in acute settings. LINQ II provides long-term, continuous monitoring for up to 4.5 years, with its value realized over time through enhanced accuracy in detecting infrequent arrhythmias and reducing false alerts, thereby improving diagnostic yield and clinic efficiency.